Table 1.
Baseline characteristics of total study sample and by baseline hypertension status.
| Characteristic | All participants (n=11,934) | Below stage 2 hypertension (n=10,665) | Stage 2 hypertension (n=1269) | P valuea | ||||||
| Female, n (%) | 8346 (69.93) | 7539 (70.69) | 807 (63.59) | <.001 | ||||||
| Age (years), n (%) |
|
|
|
<.001 | ||||||
|
|
<40 | 2929 (24.54) | 2697 (25.29) | 232 (18.28) |
|
|
||||
|
|
40-59 | 6685 (56.02) | 5927 (55.57) | 758 (59.73) |
|
|
||||
|
|
≥60s | 2320 (19.44) | 2041 (19.14) | 279 (21.99) |
|
|
||||
| Weight (kg), n; mean (SD) | 11,919; 83.9 (22.1) | 10,656; 82.6 (21.6) | 1263; 93.0 (24.2) | <.001 | ||||||
| Change in weight (kg), n; mean (SD) | 7934; –0.4 (7.5) | 7111; –0.4 (7.3) | 726; –0.7 (8.7) | <.001 | ||||||
| BMI category, n (%) |
|
|
|
<.001 | ||||||
|
|
Normal | 3621 (30.34) | 3418 (32.05) | 203 (16.00) |
|
|
||||
|
|
Overweight | 3691 (30.93) | 3339 (31.31) | 352 (27.74) |
|
|
||||
|
|
Obese | 4479 (37.53) | 3803 (35.66) | 676 (53.27) |
|
|
||||
|
|
Missing | 143 (1.20) | 105 (0.98) | 38 (2.99) |
|
|
||||
| Baseline systolic blood pressure (mmHg), n; mean (SD) | 11,934; 120 (13.0) | 10,665; 118 (9.8) | 1269; 140 (19.1) | <.001 | ||||||
| Baseline diastolic blood pressure (mmHg), n; mean (SD) | 11,934; 76.0 (9.6) | 10,665; 74.4 (7.6) | 1269; 89.5 (13.4) | <.001 | ||||||
| Follow-up duration (months), n; mean (SD) | 11,934; 8.8 (9.5) | 10,665; 8.7 (9.3) | 1269; 9.8 (10.9) | .03 | ||||||
| Diabetes, n (%) | 2124 (17.80) | 1787 (16.76) | 337 (26.56) | <.001 | ||||||
| High cholesterol, n (%) | 4254 (35.65) | 3701 (34.70) | 553 (43.58) | <.001 | ||||||
| Baseline Nutriscore (0-70), n; mean (SD) | 11,934; 33.8 (8.5) | 10,665; 34.2 (8.5) | 1269; 31.3 (8.5) | <.001 | ||||||
| Change in Nutriscore, n; mean (SD) | 11,551; 1.7 (7.1) | 10,335; 1.6 (7.1) | 1196; 1.9 (7.3) | .28 | ||||||
aChi-square tests and 2-sample t tests (paired) were used to test differences for categorical and continuous variables, respectively.